CVX vs PFE: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Pfizer Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Chevron Corporation Β· Energy
$205.52
+35.9% upside to fair value
Med Conviction
Grade B
High Quality
VS
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
CVX has more upside to fair value
(+35.9%).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
CVX |
PFE |
| Current Price |
$205.52 |
$27.64 |
| Fair Value Estimate |
$279.29 |
$30.94 |
| Upside to Fair Value |
+35.9%
|
+12.0%
|
| Market Cap |
$409.3B |
$157.5B |
| Forward P/E |
β
|
β
|
| EV / EBITDA |
7.8x
|
17.4x
|
| Price / Sales |
2.0x
|
2.5x
|
| Price / FCF |
15.0x
|
14.3x
|
| Revenue Growth YoY |
+51.4%
|
+2.6%
|
| Gross Margin |
31.0%
|
71.3%
|
| Operating Margin |
15.8%
|
25.1%
|
| Return on Equity |
11.0%
|
4.9%
|
| Dividend Yield |
3.43% |
6.22% |
| FCF Yield |
6.67%
|
6.97%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow perβ¦
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating β¦
Accumulation Zones
| Metric |
CVX |
PFE |
| Zone Low |
$209.47 |
$23.21 |
| Zone High |
$237.40 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|